The health sector is working to navigate what could be the most significant changes to the U.S. vaccine program in decades.

A proposal to deregulate AI products used in health care would shift the burden of vetting those tools onto health systems.

Several pharmaceutical companies that struck drug pricing deals with the White House said they're exempt from the Medicare ...

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Since his first term, Trump has promised to lower U.S. drug prices to levels charged in other rich countries. On Friday, the ...

The choice that one person makes not to vaccinate has real costs — financial and otherwise — for their neighbors.

Under a rule proposed by the Trump administration, pharma companies and pharmacy benefit managers will still not have to post ...

Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to ...

Federal agencies that used to set up guardrails for health technology have transformed into cheerleaders for new risky technologies like AI.

The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to ...

Good morning, Pharmalittle readers. This is Allison DeAngelis, filling in for Mr. Pharmalot. Today’s newsletter is brought to you by the dark roast Keurig pods I brought with me on my holiday travels.

More Americans will be exposed to foodborne illness as a result of this year's funding cuts, food safety experts predict ...